Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-27
DOI
10.1038/s41598-017-14891-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H5 influenza, a global update
- (2017) Rhodri Harfoot et al. JOURNAL OF MICROBIOLOGY
- Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins
- (2017) Giuseppina Di Mario et al. Pathogens and Global Health
- Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge
- (2016) Abdou Nagy et al. VACCINE
- Universal influenza vaccines: Shifting to better vaccines
- (2016) Francesco Berlanda Scorza et al. VACCINE
- Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
- (2016) Caitlin E. Mullarkey et al. mBio
- Stalking influenza by vaccination with pre-fusion headless HA mini-stem
- (2016) Sophie A. Valkenburg et al. Scientific Reports
- Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum
- (2016) Wen-Tao Yang et al. Scientific Reports
- Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets
- (2015) Raffael Nachbagauer et al. JOURNAL OF VIROLOGY
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease
- (2015) Anne Benoit et al. Open Forum Infectious Diseases
- Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses
- (2015) Richard J. Webby et al. PLoS One
- T-cell-mediated cross-strain protective immunity elicited by prime–boost vaccination with a live attenuated influenza vaccine
- (2014) Junwei Li et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
- (2014) Pierre-Alexandre Bart et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging viral respiratory tract infections—environmental risk factors and transmission
- (2014) Philippe Gautret et al. LANCET INFECTIOUS DISEASES
- Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine
- (2014) Jian Yan et al. VACCINE
- Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries
- (2013) Maria D. Van Kerkhove et al. Influenza and Other Respiratory Viruses
- Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines
- (2013) Eric A. Weaver et al. PLoS One
- A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age
- (2013) Alphonse Ouédraogo et al. PLoS One
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
- (2012) Lindsey R. Baden et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
- (2012) Masaki Imai et al. NATURE
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season
- (2012) Carlos A. DiazGranados et al. VACCINE
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin
- (2011) Eric A. Weaver et al. PLoS One
- Similar T-Cell Immune Responses Induced by Group M Consensus Env Immunogens with Wild-Type or Minimum Consensus Variable Regions
- (2010) E.A. Weaver et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)
- (2010) S. S. Shrestha et al. CLINICAL INFECTIOUS DISEASES
- Adaptation of Pandemic H1N1 Influenza Viruses in Mice
- (2010) N. A. Ilyushina et al. JOURNAL OF VIROLOGY
- Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development
- (2010) M. F. Ducatez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- M2e-based universal influenza A vaccine
- (2009) Walter Fiers et al. VACCINE
- Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
- (2008) Dominick J. Laddy et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started